This growing company has turned to equity crowdfunding to expand their tech-powered pharmacy concept..
NowRx's CEO sees several benefits to crowdfunding, like not getting pressure from VCs to scale too quickly and gaining a marketing advantage.
NowRX, has returned to SeedInvest for its Series C funding round. According to the offering page, NowRX is raising capital at a pre-money valuation of $275 million. The size of the round is indicative of the ability for more mature firms to raise capital online.
This is the 4th time NowRX has utilized the SeedInvest platform with its Seris B round raising around $20 million – SeedInvest’s largest securities offering to date.